DISCOUNT ZERTIFIKAT - METLIFE Stock

Certificat

DE000ME86CT7

Real-time Bid/Ask 06:00:02 2024-06-10 EDT
44.78 EUR / 45.51 EUR +0.91% Intraday chart for DISCOUNT ZERTIFIKAT - METLIFE
Current month+0.58%
1 month+0.07%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-10 44.73 -0.02%
24-06-07 44.74 +0.99%
24-06-06 44.3 -0.20%
24-06-05 44.39 +0.09%
24-06-04 44.35 +0.20%

Delayed Quote Börse Stuttgart

Last update June 10, 2024 at 04:50 am

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying METLIFE, INC.
Issuer Morgan Stanley
WKN ME86CT
ISINDE000ME86CT7
Date issued 2024-02-05
Cap 50 $
Last trading day 2024-12-20
Maturity 2024-12-20 (194 Days)
Parity 1 : 1
Emission price 43.64
Emission volume N/A
Payment day 2024-12-31
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 30.17 %
Sideways yield 3.038 %
Sideways yield pa 5.746 %
Outperformance point 71.61 $
Break even 48.53 €
Highest since issue 44.88
Lowest since issue 43.01
Spread 0.72
Spread %1.58%
Distance Cap 20.05 $
Distance Cap %+28.62%
Max. earning 1.371
Max. earning % 3.038 %

Company Profile

MetLife, Inc. is one of the leading American insurance groups. Premiums issued break down by activity as follows: - life insurance (58.2%): sales of savings, pre-planning, and annuities insurance policies; - accident and health insurance (39.7%); - property and casualty insurance (2.1%). Premiums are distributed geographically as follows: the United States (64.2%), Asia (15.7%), Latin America (6.4%), Europe/Middle East/Africa (5.5%) and other (8.2%).
Sector
-
More about the company

Ratings for MetLife, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: MetLife, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
70.05 USD
Average target price
82.41 USD
Spread / Average Target
+17.65%
Consensus